Thyroid diseases are common clinical endocrine disorders， and their pathogenesis is generally considered to be closely related to genetic predisposition factors， immune system disorders， hormone levels， etc. Xiaoyaosan is widely used in the treatment of various thyroid diseases with excellent effects. This study summarized the relevant literature on the treatment of thyroid diseases with modified Xiaoyaosan prescriptions and their active ingredients from aspects such as theoretical analysis， clinical research， and mechanism research. Theoretical analysis revealed that Xiaoyaosan could not only disperse stagnated liver qi but also replenish deficient spleen Qi， which was consistent with the etiology and pathogenesis of thyroid diseases. Clinical studies found that Xiaoyaosan and its modified prescriptions could be widely used in the treatment of multiple thyroid diseases， such as hyperthyroidism， Hashimoto's thyroiditis， and thyroid nodules. Both the use of modified Xiaoyaosan alone and in combination with medications such as methimazole， propylthiouracil， and euthyrox could effectively improve patients' clinical symptoms. In the mechanism research， this study discovered that the whole formula of Xiaoyaosan and its modified prescriptions could inhibit inflammatory reactions， regulate immune balance， and delay liver damage during the treatment of thyroid diseases. The research on Xiaoyaosan for treating thyroid diseases mainly focused on thyroid cancer， autoimmune thyroiditis， hyperthyroidism， and hypothyroidism. The mechanisms of action mainly involved promoting cell apoptosis， inhibiting cell proliferation and migration， arresting the cell cycle， and regulating thyroid hormone levels. In conclusion， this study systematically combs and summarizes the research status of Xiaoyaosan in treating thyroid diseases through literature retrieval， aiming to provide new perspectives and new ideas for the prevention and treatment of thyroid diseases with traditional Chinese medicine.

Thyroid-associated ophthalmopathy(TAO)is a refractory orbital disease.The pathogenesis of Western medicine is complex and diverse,and it is difficult to take into account all aspects of medication.Traditional Chinese medicine(TCM)pays attention to the overall concept and syndrome differentiation and treatment,which has certain advantages in the diagnosis and treatment of TAO.The theory of"liver opens at the eyes"in TCM suggests that abnormal liver function is involved in the entire stage of TAO onset.This article summarizes and discusses the dialectical treatment approach of treating TAO from the perspective of physiological basis,key pathological mechanisms,and general principles of treatment,which hope to expand the clinical diagnosis and treatment ideas of TCM for TAO,and leverage the advantages of TCM in TAO prevention and control.

Breast cancer is a common clinical gy-necological tumor.According to the 2022 global cancer data statistics,breast cancer ranks second in terms of incidence among newly diagnosed cancer cases worldwide.Modern medicine often adopts surgical operation,chemotherapy,and other meth-ods,which have certain efficacy but also many problems such as high drug resistance rates and sig-nificant adverse reactions.Chinese patent medi-cines exhibit extensive anticancer effects.The study found that Shenyi Capsule,Pingxiao Capsule,and Zhenqi Fuzheng Granules were widely used in the treatment of breast cancer,exerting therapeu-tic effects on breast cancer by inhibiting cell prolif-eration,invasion,and metastasis,suppressing an-giogenesis,reversing cellular drug resistance,and inhibiting precancerous lesions.Meanwhile,the oral administration of Chinese patent medicines in combination with other traditional Chinese medi-cine(TCM)compounds,TCM decoctions,or mod-ern medical treatments can improve patients' quali-ty of life and reduce adverse reactions.Currently,there are numerous studies on the treatment of breast cancer with Chinese patent medicines,but a systematic summary is lacking.Therefore,this study conducted a systematic review of the mecha-nisms of action and clinical applications of Chinese patent medicines as adjuvant therapy for breast cancer,aiming to provide guidance for clinical medi-cation.

Ulcerative colitis(UC)is a recurrent,chronic,nonspecific inflammatory bowel disease.Shaoyao Decoction has shown good efficacy in the treatment of UC,which mainly regulates the balance of cytokines to achieve the purpose of treating UC.This article reviewed the research progress in the mechanism of Shaoyao Decoction in the treatment of UC from two aspects of pro-inflammatory cytokines and anti-inflammatory cytokines.Research has shown that Shaoyao Decoction can regulate the body's immune response,alleviate intestinal inflammation,protect the intestinal mucosal barrier,restore normal structure and function of the colon mucosa through pro-inflammatory cytokines such as tumor necrosis factor-α,interferon-γ,interleukin(IL)-1β,IL-6,IL-8,IL-17,and anti-inflammatory cytokines such as transforming growth factor-β,IL-4,IL-10,IL-13,which can provide reference for UC related mechanism research and clinical treatment.

Objective:This study aims to investigate the effect of androgen receptor(AR)on doxorubicin(DOX)-induced cardiomyocyte senescence and autophagy.Methods:H9C2 cardiomyocytes were cultured in vitro, and treated with 0.1 μM DOX for 48 hours to construct an aging cardiomyocytes model.An AR-overexpressing cardiomyocyte model was generated via adenovirus transfection.The cells were divided into four groups: Control group, Control+ AR-overexpression group, DOX group and DOX+ AR-overexpression group.Senescence-associated β-galactosidase staining was performed to assess the positive rate of β-galactosidase staining in myocardial cells; RT-PCR technology was used to detect the mRNA expression levels of senescence-related genes( P21, P53, IL-1 β, IL-6, MCP-1), the inflammasome NLRP3, and autophagy regulatory genes( TFEB and P62)in cardiomyocytes; the Western blot method was used to detect the protein expression levels of P21, AR, TFEB, P62, LC3-Ⅰ, LC3-Ⅱ, and the LC3-Ⅱ/LC3-Ⅰ ratio. Results:Compared with the Control group, the DOX group exhibited a significantly increased positive rate of SA-β-gal staining in myocardial cells( P<0.001). The mRNA expression of P21, P53, IL-1 β, IL-6, MCP-1, and NLRP3 were upregulated(all P<0.05), accompanied by elevated P21 protein expression( P<0.05), while the AR protein expression was downregulated( P<0.05). The LC3-Ⅱ/LC3-Ⅰ ratio was increased significantly( P<0.01), whereas both mRNA and protein expression levels of TFEB and P62 were reduced( P<0.05). Compared with the DOX group, the DOX+ AR-overexpression group exhibited a significantly reduced positive rate of SA-β-gal staining in myocardial cells( P<0.000 1), a decrease in P21 protein expression( P<0.05), a decrease in LC3-Ⅱ/LC3-Ⅰ ratio( P<0.01), and an increase in TFEB and P62 protein expression levels( P<0.05). Conclusions:AR enhances the autophagic clearance function of aging myocardial cells and inhibits cell aging phenotype through upregulating the expression levels of TFEB and P62.

Objective To evaluate the clinical efficacy of Huanglian Heye Formula(composed of Nelumbinis Folium,Coicis Semen,Atractylodis Rhizoma,Glycyrrhizae Radix et Rhizoma,Coptidis Rhizoma,Crataegi Fructus,and Atractylodis Macrocephalae Rhizoma)combined with insulin aspart in treating obese patients with type 2 diabetes mellitus(T2DM)presenting damp-heat obstructing middle jiao syndrome.Methods A total of 94 obese T2DM patients with damp-heat obstructing middle jiao syndrome were treated at the Endocrinology Department of the First Affiliated Hospital of Henan University of Chinese Medicine from April 2022 to January 2024.The patients were randomly assigned to the control group and the observation group,with 47 patients in each group.The control group was treated with insulin aspart,and the observation group was treated with Huanglian Heye Formula plus insulin aspart,both groups were treated for 12 weeks.Changes in traditional Chinese medicine(TCM)syndrome scores,lipid metabolism parameters[total cholesterol(TC),triglycerides(TG),low-density lipoprotein cholesterol(LDL-C)],obesity indicators[waist-to-hip ratio(WHR),body mass index(BMI),glucose metabolism markers[glycated hemoglobin(HbA1c),2-hour postprandial glucose(2hPG),fasting plasma glucose(FPG)],and serological indicators(visceral adipose tissue-derived serine protease inhibitor[VASPIN],homeostasis model assessment of[3-cell function(HOMA-β)]were observed before and after treatment.Clinical efficacy and safety were evaluated.Results(1)The observation group demonstrated significantly higher total efficacy[93.62％(44/47)]compared to the control group[78.72％(37/47);the intergroup comparison(by chi-square test)showed that the efficacy in the observation group was superior to the control group(P＜0.05).(2)Both groups showed reduced TCM syndrome scores(heaviness in head/body,epigastric fullness,sticky/foul-smelling stools,halitosis,dry/bitter mouth,heartburn/vomiting,yellowish urine,and emotional distress;all P＜0.05),with greater improvements in the observation group(P＜0.01).(3)Lipid profiles of TC,TG and LDL-C were improved in both groups(P＜0.05),with more significant reductions in the observation group(P＜0.01).(4)Obesity indicators(WHR,BMI)decreased in both groups(P＜0.05),showing superior reductions in the observation group(P＜0.05 or P＜0.01).(5)Glucose metabolism markers(HbA1c,2hPG,FPG)were significantly lowered in both groups(P＜0.05),with the observation group achieving better outcomes(P＜0.01).(6)Serological analysis revealed increased VASPIN and HOMA-[3 levels in both groups(P＜0.05),with more pronounced elevations in the observation group(P＜0.01).(7)No severe adverse events occurred.The incidence of adverse reactions was 8.51％(4/47)in the observation group versus 6.38％(3/47)in the control group(P＞0.05).Conclusion Huanglian Heye Formula combined with insulin aspart significantly improves clinical outcomes in obese T2DM patients with damp-heat obstructing middle jiao syndrome by protecting pancreatic[3-cell function,reducing body mass,ameliorating glucose/lipid metabolism,and modulating VASPIN expression,with demonstrated safety.

Ulcerative colitis(UC)is a recurrent,chronic,nonspecific inflammatory bowel disease.Shaoyao Decoction has shown good efficacy in the treatment of UC,which mainly regulates the balance of cytokines to achieve the purpose of treating UC.This article reviewed the research progress in the mechanism of Shaoyao Decoction in the treatment of UC from two aspects of pro-inflammatory cytokines and anti-inflammatory cytokines.Research has shown that Shaoyao Decoction can regulate the body's immune response,alleviate intestinal inflammation,protect the intestinal mucosal barrier,restore normal structure and function of the colon mucosa through pro-inflammatory cytokines such as tumor necrosis factor-α,interferon-γ,interleukin(IL)-1β,IL-6,IL-8,IL-17,and anti-inflammatory cytokines such as transforming growth factor-β,IL-4,IL-10,IL-13,which can provide reference for UC related mechanism research and clinical treatment.

Thyroid-associated ophthalmopathy(TAO)is a refractory orbital disease.The pathogenesis of Western medicine is complex and diverse,and it is difficult to take into account all aspects of medication.Traditional Chinese medicine(TCM)pays attention to the overall concept and syndrome differentiation and treatment,which has certain advantages in the diagnosis and treatment of TAO.The theory of"liver opens at the eyes"in TCM suggests that abnormal liver function is involved in the entire stage of TAO onset.This article summarizes and discusses the dialectical treatment approach of treating TAO from the perspective of physiological basis,key pathological mechanisms,and general principles of treatment,which hope to expand the clinical diagnosis and treatment ideas of TCM for TAO,and leverage the advantages of TCM in TAO prevention and control.

Breast cancer is a common clinical gy-necological tumor.According to the 2022 global cancer data statistics,breast cancer ranks second in terms of incidence among newly diagnosed cancer cases worldwide.Modern medicine often adopts surgical operation,chemotherapy,and other meth-ods,which have certain efficacy but also many problems such as high drug resistance rates and sig-nificant adverse reactions.Chinese patent medi-cines exhibit extensive anticancer effects.The study found that Shenyi Capsule,Pingxiao Capsule,and Zhenqi Fuzheng Granules were widely used in the treatment of breast cancer,exerting therapeu-tic effects on breast cancer by inhibiting cell prolif-eration,invasion,and metastasis,suppressing an-giogenesis,reversing cellular drug resistance,and inhibiting precancerous lesions.Meanwhile,the oral administration of Chinese patent medicines in combination with other traditional Chinese medi-cine(TCM)compounds,TCM decoctions,or mod-ern medical treatments can improve patients' quali-ty of life and reduce adverse reactions.Currently,there are numerous studies on the treatment of breast cancer with Chinese patent medicines,but a systematic summary is lacking.Therefore,this study conducted a systematic review of the mecha-nisms of action and clinical applications of Chinese patent medicines as adjuvant therapy for breast cancer,aiming to provide guidance for clinical medi-cation.

Objective:This study aims to investigate the effect of androgen receptor(AR)on doxorubicin(DOX)-induced cardiomyocyte senescence and autophagy.Methods:H9C2 cardiomyocytes were cultured in vitro, and treated with 0.1 μM DOX for 48 hours to construct an aging cardiomyocytes model.An AR-overexpressing cardiomyocyte model was generated via adenovirus transfection.The cells were divided into four groups: Control group, Control+ AR-overexpression group, DOX group and DOX+ AR-overexpression group.Senescence-associated β-galactosidase staining was performed to assess the positive rate of β-galactosidase staining in myocardial cells; RT-PCR technology was used to detect the mRNA expression levels of senescence-related genes( P21, P53, IL-1 β, IL-6, MCP-1), the inflammasome NLRP3, and autophagy regulatory genes( TFEB and P62)in cardiomyocytes; the Western blot method was used to detect the protein expression levels of P21, AR, TFEB, P62, LC3-Ⅰ, LC3-Ⅱ, and the LC3-Ⅱ/LC3-Ⅰ ratio. Results:Compared with the Control group, the DOX group exhibited a significantly increased positive rate of SA-β-gal staining in myocardial cells( P<0.001). The mRNA expression of P21, P53, IL-1 β, IL-6, MCP-1, and NLRP3 were upregulated(all P<0.05), accompanied by elevated P21 protein expression( P<0.05), while the AR protein expression was downregulated( P<0.05). The LC3-Ⅱ/LC3-Ⅰ ratio was increased significantly( P<0.01), whereas both mRNA and protein expression levels of TFEB and P62 were reduced( P<0.05). Compared with the DOX group, the DOX+ AR-overexpression group exhibited a significantly reduced positive rate of SA-β-gal staining in myocardial cells( P<0.000 1), a decrease in P21 protein expression( P<0.05), a decrease in LC3-Ⅱ/LC3-Ⅰ ratio( P<0.01), and an increase in TFEB and P62 protein expression levels( P<0.05). Conclusions:AR enhances the autophagic clearance function of aging myocardial cells and inhibits cell aging phenotype through upregulating the expression levels of TFEB and P62.